← Back to Clinical Trials
Recruiting NCT05834920

NCT05834920 Effects of Neurofeedback and Transcranial Pulse Stimulation on Attention

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05834920
Status Recruiting
Phase —
Sponsor The University of Hong Kong
Condition Attention Difficulties
Study Type INTERVENTIONAL
Enrollment 180 participants
Start Date 2023-03-17
Primary Completion 2025-06

Eligibility & Interventions

Sex All sexes
Min Age 20 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Transcranial pulse stimulation (TPS)Neurofeedback

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 180 participants in total. It began in 2023-03-17 with a primary completion date of 2025-06.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The present study aims to examine and compare the effectiveness of transcranial pulse stimulation and neurofeedback among adults who are weak in attention.

Eligibility Criteria

Inclusion Criteria: * Aged 20 years and above * Right-handed * Normal/corrected hearing and vision * Having basic literacy skills * Having sustained attention scores below the threshold Exclusion Criteria: * Having medical history related to brain * Having mild cognitive impairment * Showing symptoms of depression and anxiety * Having intellectual disability based on IQ scores * Having diagnoses of any psychiatric or cognitive disorders besides attention deficit hyperactivity disorder (ADHD) inattentive and combined types * Having long-term history of smoking cigarettes * Engaged in alcohol and/or substance abuse * Having history of hemophilia or other blood clotting disorders or thrombosis * Having corticosteroid treatment within the last six weeks before first intervention * Having contraindications for MRI scanning

Contact & Investigator

Central Contact

Maria T Wijaya, PhD

✉ mtwijaya@hku.hk

📞 (852) 3917-8927

Frequently Asked Questions

Who can join the NCT05834920 clinical trial?

This trial is open to participants of all sexes, aged 20 Years or older, studying Attention Difficulties. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05834920 currently recruiting?

Yes, NCT05834920 is actively recruiting participants. Contact the research team at mtwijaya@hku.hk for enrollment information.

Where is the NCT05834920 trial being conducted?

This trial is being conducted at Hong Kong, Hong Kong.

Who is sponsoring the NCT05834920 clinical trial?

NCT05834920 is sponsored by The University of Hong Kong. The trial plans to enroll 180 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology